Buscar
Mostrando ítems 1-10 de 134
Comparing The Copenhagen Index (cph-i) And Risk Of Ovarian Malignancy Algorithm (roma): Two Equivalent Ways To Differentiate Malignant From Benign Ovarian Tumors Before Surgery?
(Academic Press Inc Elsevier ScienceSan Diego, 2016)
Cell proliferation activity unrelated to COX-2 expression in ovarian tumors
(Blackwell PublishingOxfordInglaterra, 2007)
Heparanase-2 Expression in Normal Ovarian Epithelium and in Benign and Malignant Ovarian Tumors
(Lippincott Williams & Wilkins, 2009-12-01)
Introduction: Studies have highlighted the changes that take place in the environment between the cell and the extracellular matrix during the process of neoplastic expansion. Several papers have associated the expression ...
Caracterização da resposta imune celular em mulheres com câncer de ovário
(Universidade Estadual Paulista (UNESP), 2014)
Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors
(BLACKWELL PUBLISHING, 2008)
Pseudomyxoma peritonei (PMP) is a clinical condition initially thought to be related to ovarian mucinous tumors; however, immunohistochemistry and molecular biology techniques have convincingly made the link to appendiceal ...
HER-2 and cancer antigen 125 evaluation in ovarian borderline tumors by immunohistochemistry and fluorescence in situ hybridization
(Blackwell Publishing IncMaldenEUA, 2004)
A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses
(HOSPITAL CLINICAS, UNIV SAO PAULOSAO PAULO, 2012)
OBJECTIVE: Differentiation between benign and malignant ovarian neoplasms is essential for creating a system for patient referrals. Therefore, the contributions of the tumor markers CA125 and human epididymis protein 4 ...
Caracterização da resposta imune celular em mulheres com câncer de ovário
(Universidade Estadual Paulista (Unesp), 2010-02-26)
O câncer de ovário apresenta diagnóstico tardio e alta letalidade, devido à falta de biomarcadores sensíveis e específicos e à rápida progressão desse câncer, assintomático em estadios iniciais. As células imunes têm a ...
Caracterização da resposta imune celular em mulheres com câncer de ovário
(Universidade Estadual Paulista (Unesp), 2010-02-26)
O câncer de ovário apresenta diagnóstico tardio e alta letalidade, devido à falta de biomarcadores sensíveis e específicos e à rápida progressão desse câncer, assintomático em estadios iniciais. As células imunes têm a ...